Medscape (7/25, Anderson, Subscription Publication) reports the sleep drugs zaleplon, zolpidem, and zopiclon may increase the risk of fractures in patients with dementia, according to a study presented at the Alzheimer’s Association International Conference 2018. In the study that included people “who had received a Z-drug prescription (n = 2952) and those who had not (n = 1651),” the researchers found that the “so-called Z drugs were found to increase overall fracture risk by 40% and the risk for hip fracture by 59%.” HealthDay (7/25, Preidt) also covers the story. (SOURCE: APA Headlines)